Mengniu (2319.HK): What‘s New from Citi‘s Consumer Corp Day: 5M26 Sales Up HSD YoY, Ahead of FY26E Guidance

Research evidence excerpt

Mengniu (2319.HK): What‘s New from Citi‘s Consumer Corp Day: 5M26 Sales Up HSD YoY, Ahead of FY26E Guidance

Flash |

21 Jun 2026 17:08:23 ET │ 11 pages

Mengniu (2319.HK)

What’s New from Citi’s Consumer Corp Day: 5M26 Sales Up HSD YoY,

Ahead of FY26E Guidance

CITI’S TAKE Buy

Per management who attended Citi’s Consumer Corp Day, group top-line Price (18 Jun 26 16:10) HK$15.57

expanded by HSD YoY in 5M26, above 2026E full-year guidance for MSD Target price HK$22.70

of sales growth YoY (see March 26 note: Mengniu – Analyst Briefing

Expected share price return 45.8% Takeaways: Positive 26E Outlook). Mengniu’s 5M26 top-line growth is

one of the strongest among big-cap China consumer staple companies, in Expected dividend yield 2.6%

our view. We expect its OPM to be stable YoY in 2026E, if not slightly Expected total return 48.4%

better. We anticipate core NP (ex-impairment loss) growth to be stronger Market Cap HK$60,357M

than EBIT growth in 2026E, given substantial YoY reduction of “other US$7,702M

expenses” (especially bulk whole-milk powder inventory write-down loss)

and associate losses (especially at China Modern Dairy). Mengniu was the

most discussed China consumer stock in our recent marketing in

UK/Europe (see our June 16 note: China Consumer – UK/Europe Xiaopo Wei, CFAAC

marketing feedback; Most discussed China consumer stocks). +852-2501-2472

Mengniu remains our Top Buy in the China consumer staple space. xiaopo.wei@citi.com

Vincent Young

Continuously strong 5M26 sales — Per management, company top-line expanded +852-2501-2738

HSD YoY in 5M26, maintaining its strong momentum from 1Q26 (+HSD YoY). Volume vincent.young@citi.com

growth contributed more than 50% of the sales growth, while ASP contributed less

than 50% of the top-line expansion in 5M26, per management.